M
CME icon

Mirova’s CME Group CME Stock Holding History

Mirova’s Portfolio CME Stock Details CME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-588
Closed -$98.9K – 179
2022
Q4 		$98.9K Hold
588
– – 0.02% 176
2022
Q3 		$104K Sell
588
-1,503
-72% -$297K 0.02% 170
2022
Q2 		$428K Buy
+2,091
New +$443K 0.06% 135
2020
Q4 		– Sell
-56
Closed -$9K – 181
2020
Q3 		$9K Sell
56
-278
-83% -$46.8K ﹤0.01% 190
2020
Q2 		$54K Sell
334
-8
-2% -$1.43K 0.01% 99
2020
Q1 		$59K Sell
342
-154
-31% -$30.7K 0.02% 90
2019
Q4 		$100K Buy
496
+160
+48% +$32.8K 0.03% 99
2019
Q3 		$71K Buy
336
+30
+10% +$6.27K 0.01% 103
2019
Q2 		$59K Buy
+306
New +$56.4K 0.01% 106

Other funds holding CME

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $34.1B AUM 20.22% 1-Year Est. Return

Mirova's CME Position: Q1 2023 in Review

Mirova sold out of CME Group (CME) in Q1 2023, closing a stake of 588 shares — an estimated $98.9K sold.

Mirova first reported a position in CME in Q2 2019 and held it in 9 quarters. The position peaked at $428K in Q2 2022. 1,171 funds tracked by Wall St. Rank hold CME as of Q1 2023.

  • Mirova reported no remaining CME Group position as of Q1 2023 after selling out during the quarter.
  • Mirova sold 588 CME Group shares in Q1 2023, an estimated $98.9K.
  • Mirova first reported a position in CME Group in Q2 2019 and held it in 9 quarters.
  • Mirova's CME Group position peaked at $428K in Q2 2022.
  • 1,171 funds tracked by Wall St. Rank held CME Group as of Q1 2023.

Based on Mirova's 13F filing for Q1 2023, filed 12 May 2023.